Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginie Dufrost

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Annals of Internal Medicine|October 15, 2019
Direct Oral Anticoagulants in Antiphospholipid Syndrome: Too Early or Too Late?Denis Wahl, Virginie Dufrost
Autoimmunity Reviews|November 16, 2020
Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trialsVirginie Dufrost, Denis Wahl, Stéphane Zuily
Journal of Thrombosis and Haemostasis : JTH|March 9, 2019
Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: A systematic review and meta-analysis: CommentVirginie Dufrost, Denis Wahl, Stéphane Zuily
Current Rheumatology Reports|November 5, 2016
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the LiteratureVirginie Dufrost, Jessie Risse, Stéphane Zuily, et al.
Current Rheumatology Reports|May 15, 2020
Health-Related Quality of Life in Antiphospholipid Syndrome: Current Knowledge and Future PerspectivesMarie Desnoyers, Virginie Dufrost, Denis Wahl, et al.
Current Rheumatology Reports|July 26, 2017
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to CommentVirginie Dufrost, Jessie Risse, Denis Wahl, et al.
Rheumatology (Oxford, England)|January 27, 2018
Comment on: Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome: replyVirginie Dufrost, Jessie Risse, Denis Wahl, et al.
Rheumatology (Oxford, England)|April 22, 2017
Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndromeVirginie Dufrost, Jessie Risse, Stéphane Kirchner, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2024
Epidemiology, natural history, diagnosis, and management of ovarian vein thrombosis: a scoping reviewMargaux Monnet, Virginie Dufrost, Denis Wahl, et al.
European Journal of Internal Medicine|October 21, 2020
Risk of thrombosis, pregnancy morbidity or death in antiphospholipid antibodies positive patients with or without thrombocytopeniaThomas Moulinet, Virginie Dufrost, Isabelle Clerc-Urmès, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Annals of Internal Medicine|October 15, 2019
Direct Oral Anticoagulants in Antiphospholipid Syndrome: Too Early or Too Late?Denis Wahl, Virginie Dufrost
Autoimmunity Reviews|November 16, 2020
Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trialsVirginie Dufrost, Denis Wahl, Stéphane Zuily
Journal of Thrombosis and Haemostasis : JTH|March 9, 2019
Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: A systematic review and meta-analysis: CommentVirginie Dufrost, Denis Wahl, Stéphane Zuily
Current Rheumatology Reports|November 5, 2016
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the LiteratureVirginie Dufrost, Jessie Risse, Stéphane Zuily, et al.
Current Rheumatology Reports|May 15, 2020
Health-Related Quality of Life in Antiphospholipid Syndrome: Current Knowledge and Future PerspectivesMarie Desnoyers, Virginie Dufrost, Denis Wahl, et al.
Current Rheumatology Reports|July 26, 2017
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to CommentVirginie Dufrost, Jessie Risse, Denis Wahl, et al.
Rheumatology (Oxford, England)|January 27, 2018
Comment on: Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome: replyVirginie Dufrost, Jessie Risse, Denis Wahl, et al.
Rheumatology (Oxford, England)|April 22, 2017
Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndromeVirginie Dufrost, Jessie Risse, Stéphane Kirchner, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2024
Epidemiology, natural history, diagnosis, and management of ovarian vein thrombosis: a scoping reviewMargaux Monnet, Virginie Dufrost, Denis Wahl, et al.
European Journal of Internal Medicine|October 21, 2020
Risk of thrombosis, pregnancy morbidity or death in antiphospholipid antibodies positive patients with or without thrombocytopeniaThomas Moulinet, Virginie Dufrost, Isabelle Clerc-Urmès, et al.
Pageof 4